Kristian Reich
Chief Scientific Officer · 1 filing · Latest: Jun 15, 2026
MoonLake Immunotherapeutics
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MLTX | Kristian Reich | Chief Scientific Officer | Jun 17, 2026 | Sale | $19.43 | 50,000 | $971.5K | 2,824,551 | |
MLTX | Kristian Reich | Chief Scientific Officer | Jun 16, 2026 | Sale | $18.70 | 50,000 | $935.0K | 2,874,551 | |
MLTX | Kristian Reich | Chief Scientific Officer | Jun 15, 2026 | Sale | $18.89 | 50,000 | $944.5K | 2,924,551 | |
MLTX | Reich Kristian | — | Jun 15, 2026 | Proposed Sale | $19.00 | 150,000 | $2.9M | — | |
MLTX | Kristian Dieter Johannes Reich | — | Dec 8, 2025 | Proposed Sale | $14.80 | 202,908 | $3.0M | — |